期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Inhibitory effects of rapamycin on the different stages of hepatic fibrosis 被引量:4
1
作者 yun jeung kim Eaum Seok Lee +4 位作者 Seok Hyun kim Heon Young Lee Seung Moo Noh Dae Young Kang Byung Seok Lee 《World Journal of Gastroenterology》 SCIE CAS 2014年第23期7452-7460,共9页
AIM:To investigate and compare the inhibitory effects of rapamycin in the different stages of liver fibrosis.METHODS:We performed bile duct ligation(BDL)in male Wistar rats(n=24).The experimental rats were classified ... AIM:To investigate and compare the inhibitory effects of rapamycin in the different stages of liver fibrosis.METHODS:We performed bile duct ligation(BDL)in male Wistar rats(n=24).The experimental rats were classified into four groups:the BDL+/Rapa-group(untreated control,n=4),the BDL+/Rapa+group(treated14 d after BDL,n=8),the BDL+/Rapa++group(treated on the day after BDL,n=8),and the BDL-/Rapagroup(un-treated,sham-operated control,n=4).The BDL+/Rapa+and BDL+/Rapa++groups were administered rapamycin(2 mg/kg)for 28 d.The liver tissues were tested by immunohistochemical staining forα-smooth muscle actin(α-SMA)and cytokeratin.RESULTS:The liver mRNA levels of transforming growth factor(TGF)-β1 and platelet-derived growth factor(PDGF)were measured using the polymerase chain reaction.The protein levels of liver p70s6K and p-p70s6k were determined using Western blotting.α-SMA expression was lowest in the BDL+/Rapa++group.TGF-β1and PDGF expression levels in the rapamycin-treated group were lower than those in the un-treated group and higher than those in the control groups(TGF-β1:0.23±0.00 vs 0.34±0.01,0.23±0.0 vs 0.09±0.00,P<0.0001;PDGF:0.21±0.00 vs 0.34±0.01,0.21±0.0 vs 0.09±0.00,P<0.0001).The p70s6k and p-p70s6k levels decreased in the treated groups and were lowest in the BDL+/Rapa++group(p70s6k:1.05±0.17 vs 1.30±0.56,0.40±0.01 vs 1.30±0.56,P<0.0001;p-p70s6k:1.40±0.5 vs 1.67±0.12,0.70±0.01 vs 1.67±0.12,P<0.0001).CONCLUSION:The results of our study indicate that rapamycin has inhibitory effects on liver fibrosis,and the treatment is most effective in the early stages of fibrosis. 展开更多
关键词 Liver CIRRHOSIS SIROLIMUS TRANSFORMING growth FACT
下载PDF
Reactivation of tuberculosis in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A report of 3 cases 被引量:3
2
作者 yun jeung kim Pyung Gohn Goh +4 位作者 Hee Seok Moon Eaum Seok Lee Seok Hyun kim Byung Seok Lee Heon Young Lee 《World Journal of Radiology》 CAS 2012年第5期236-240,共5页
Pulmonary tuberculosis is an opportunistic infection that can be reactivated in immunocompromised conditions, for example, in malignancy or after liver transplantation. Hepatocellular carcinoma (HCC) has a high mortal... Pulmonary tuberculosis is an opportunistic infection that can be reactivated in immunocompromised conditions, for example, in malignancy or after liver transplantation. Hepatocellular carcinoma (HCC) has a high mortality rate because it is frequently diagnosed at an advanced stage. Although surgical resection is the established curative measure for HCC, it is only feasible for earlystage HCC. Transcatheter arterial chemoembolization (TACE) is the most common treatment modality for patients with unresectable HCC. However, repeated TACE sessions and, occasionally, the tumor itself can further impair the reserve hepatic function and immunity. We report 3 recent cases of HCC with reactivation of pulmonary tuberculosis after TACE. 展开更多
关键词 HEPATOCELLULAR carcinoma REACTIVATION TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION TUBERCULOSIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部